Show simple item record

dc.contributor.authorMungo, C
dc.contributor.authorCohen, CR
dc.contributor.authorMaloba, M
dc.contributor.authorBukusi, EA
dc.contributor.authorHuchko, MJ
dc.date.accessioned2013-10-08T12:42:11Z
dc.date.available2013-10-08T12:42:11Z
dc.date.issued2013
dc.identifier.citationInt J Gynaecol Obstet. 2013 Sep 10en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/24095308
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57480
dc.description.abstractOBJECTIVE: To determine the prevalence of invasive cervical cancer (ICC) and assess access to, and outcomes of, treatment for ICC among HIV-infected women in Kisumu, Kenya. METHODS: We performed a retrospective chart review to identify women diagnosed with ICC between October 2007 and June 2012, and to examine the impact of a change in the referral protocol. Prior to June 2009, all women with ICC were referred to a regional hospital. After this date, women with stage IA1 disease were offered treatment with loop electrosurgical excision procedure (LEEP) in-clinic. RESULTS: Of 4308 women screened, 58 (1.3%) were diagnosed with ICC. The mean age at diagnosis was 34years (range, 22-50years). Fifty-four (93.1%) women had stage IA1 disease, of whom 36 (66.7%) underwent LEEP, 7 (12.9%) had a total abdominal hysterectomy, and 11 (20.4%) had unknown or no treatment. At 6, 12, and 24months after LEEP, 8.0% (2/25), 25.0% (6/24), and 41.2% (7/17) of women had a recurrence of cervical intraepithelial neoplasia 2 or worse, respectively. CONCLUSION: Most HIV-positive women diagnosed with ICC through screening had early-stage disease. The introduction of LEEP in-clinic increased access to treatment; however, recurrence was high, indicating the need for continued surveillance.en
dc.language.isoenen
dc.subjectCervical cancer screeningen
dc.subjectHIVen
dc.subjectKenyaen
dc.subjectLoop Electrosurgical Excision Procedureen
dc.subjectResource-limited settingsen
dc.titlePrevalence, characteristics, and outcomes of HIV-positive women diagnosed with invasive cancer of the cervix in Kenya.en
dc.typeArticleen
local.publisherDoris Duke Clinical Research Fellow, University of California San Francisco, San Francisco, USAen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record